Recombinant Human FMO1 Protein，His

FMO1 (Flavin-containing Monooxygenase 1) is a critical enzyme in the family of flavin-dependent monooxygenases, involved in the metabolism of various endogenous and exogenous substrates, including drugs and xenobiotics. The study of FMO1 has gained significant attention due to its role in drug metabolism, detoxification processes, and individual variability in drug responses, which can lead to adverse drug reactions. Notably, FMO1 is expressed in various tissues, including the liver, and its activity can be influenced by genetic polymorphisms, disease states, and environmental factors. The recombinant production of FMO1 has become essential for elucidating its enzymatic mechanisms and substrate specificity, facilitating high-throughput screening in drug discovery. Furthermore, understanding the structural and functional properties of FMO1 is crucial for designing better therapeutic agents and predicting drug interactions. Recent advances in recombinant DNA technology and protein purification methods have enabled researchers to produce large quantities of active FMO1, fostering studies that explore its role in metabolism and the potential implications for personalized medicine. Overall, FMO1 recombinant protein research provides insights into the complexities of human metabolism and the impact of genetic diversity on pharmacotherapy.